Travere Therapeutics, Inc. TVTX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s software and technology licenses, net?
- Travere Therapeutics, Inc. (TVTX) reported software and technology licenses, net of $8.48M in Q1 2026.
- How has Travere Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Travere Therapeutics, Inc.'s software and technology licenses, net decreased by 54.6% year-over-year, from $18.69M to $8.48M.
- What is the long-term trend for Travere Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s software and technology licenses, net has grown at a 2.6% compound annual growth rate (CAGR), from $7.81M to $8.88M.